PLTR vs PYXS · P/E 584, rev $4.48B vs rev $2.8M
Palantir Technologies Inc. Class A Common Stock (PLTR) versus Pyxis Oncology Inc (PYXS) — a side-by-side from cached financials, not a winner call.
Palantir Technologies Inc. Class A Common Stock (PLTR) is a software - infrastructure company listed on US. It is led by Alex Karp.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Latest reported PLTR revenue for 2025-12-31 was $4.48B. Net income was $1.63B. Revenue was up 56.2% from 2024-12-31 to 2025-12-31. PLTR currently screens at market cap $317.08B and trailing P/E 584.2.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
PLTR currently screens at market cap $317.08B and trailing P/E 584.2. PYXS currently screens at market cap $109.6M.
Not investment advice. Open the PLTR and PYXS stock pages for the full models.
Not investment advice.